Which Groups of Children Are at More Risk of Fatality during COVID-19 Pandemic? A Case-Control Study in Yazd, Iran

Table 3

Signs and symptoms in preadmission and on-admission time in deceased and survived children with COVID-19.

Variables	Preadmission; (OR ref: survived group)				On-admission; (OR ref: survived group)
	Deceased (n = 24)	Survived (n = 167)		OR (95% CI)	Deceased (n = 24)	Survived (n = 167)		OR (95% CI)
Fever	17 (70.8%)	111 (66.4%)	0.67	1.22 (0.48–3.12)	18 (75%)	104 (62.27%)	0.22	1.81 (0.68–4.82)
Vomiting	10 (41.66%)	46 (27.5%)	0.15	1.88 (0.78–4.53)	9 (37.5%)	37 (22.15%)	0.1	2.1 (0.85–5.2)
Cough	7 (29.1%)	55 (32.9%)	0.71	0.84 (0.33–2.14)	4 (16.66%)	55 (32.9%)	0.10	0.4 (0.13–1.25)
Diarrhea	6 (25%)	49 (29.34%)	0.66	0.8 (0.3–2.14)	7 (29.16%)	41 (24.5%)	0.62	1.26 (0.49–3.26)
Dyspnea	6 (25%)	46 (27.5%)	0.79	0.88 (0.33–2.34)	9 (37.5%)	33 (19.76%)	0.05	2.44 (0.98–6.05)
Seizure	2 (8.3%)	20 (11.97%)	0.6	0.67 (0.15–3.06)	2 (8.2%)	19 (11.37%)	0.66	0.7 (0.15–3.25)
Myalgia	1 (4.1%)	27 (16.16%)	0.12	0.22 (0.03–1.74)	1 (4.1%)	18 (10.77%)	0.48	0.36 (0.05–2.83)
Cyanosis	0	4 (2.3%)	1.00	—	1 (4.1%)	7 (4.19%)	0.99	0.99 (0.18–8.45)
Headache	0	25 (14.9%)	0.15	0.25 (0.03–1.91)	1 (4.1%)	15 (8.9%)	0.27	0.44 (0.06–3.5)

Dyspnea on admission was observed significantly more in the deceased group compared to the survived group.